Autoantibodies against Oxidised Low-Density Lipoprotein in Patients with Obstructive Sleep Apnoea
暂无分享,去创建一个
[1] G. Siest,et al. Low and very low density lipoprotein composition and resistance to copper-induced oxidation are not notably modified in smokers. , 1997, Clinica chimica acta; international journal of clinical chemistry.
[2] J. Wu,et al. Autoantibodies against oxidized LDL. A potential marker for atherosclerosis. , 1997, Clinics in laboratory medicine.
[3] T. Lehtimäki,et al. In vivo low density lipoprotein oxidation relates to coronary reactivity in young men. , 1997, Journal of the American College of Cardiology.
[4] C. A. van der Merwe,et al. Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers. , 1996, Atherosclerosis.
[5] J. Boer,et al. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. , 1996, Atherosclerosis.
[6] J. Hedner,et al. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. , 1996, Journal of hypertension.
[7] M. Olschewski,et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. , 1996, Circulation.
[8] G. Bellomo,et al. Presence of autoantibodies against oxidatively modified low‐density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low‐density lipoprotein oxidation , 1995, Journal of hypertension.
[9] L. Tenkanen,et al. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. , 1994, Archives of internal medicine.
[10] T. Ledue,et al. Changes in serum antibodies to oxidised low-density lipoprotein with age , 1994, The Lancet.
[11] V. Armstrong,et al. Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease , 1994, The Lancet.
[12] C. Zwillich,et al. Possible atherogenic effects of hypoxia during obstructive sleep apnea. , 1993, Sleep.
[13] T. Young,et al. The occurrence of sleep-disordered breathing among middle-aged adults. , 1993, The New England journal of medicine.
[14] P. Jennum,et al. Epidemiology of snoring and obstructive sleep apnoea in a Danish population, age 30–60 , 1992, Journal of sleep research.
[15] J. Salonen,et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.
[16] S. Manuck,et al. Role of sympathoadrenal medullary activation in the initiation and progression of atherosclerosis. , 1991, Circulation.
[17] I. Mcdougall,et al. Roles of Thrombin and Platelet Membrane Glycoprotein IIb/IIIa in Platelet‐Subendothelial Deposition After Angioplasty in an Ex Vivo Whole Artery Model , 1991, Circulation.
[18] Sanjiv Kaul,et al. Prediction of Outcome After Mitral Valve Replacement in Patients With Symptomatic Chronic Mitral Regurgitation: The Importance of Left Atrial Size , 1991, Circulation.
[19] K. O’malley,et al. SLEEP APNOEA AND HYPERTENSION , 1985, The Lancet.
[20] P. Helin,et al. Arteriosclerosis in Rabbit Aorta Induced By Systemic Hypoxia , 1969, Angiology.
[21] S. Saarelainen,et al. Circulating endothelin-1 in obstructive sleep apnea. , 1997, Endothelium : journal of endothelial cell research.